Furthermore, the issue of false positives in AFP testing has restricted its widespread use in HCC screening, which is one of the critical factors contributing to the difficulty of early diagnosis and high mortality rate of HCC [2]. The gene discussed is AFP; the disease is hepatocellular carcinoma.